content

KemPharm Enhances Pipeline with the Addition of KP879, a Potential New Treatment for Stimulant Use Disorder

KemPharm, Inc. , a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced the addition of a new product candidate,...

PANTHERx Specialty Pharmacy and RxCrossroads by McKesson Collaborate to Streamline the Channel for Precision Medicine Therapies

PANTHERxยฎ Specialty Pharmacy, The Rare Disease Specialty Pharmacy , and RxCrossroadsย  by McKesson, the leading commercial solutions partner for life sciences companies, announced their...

PANTHERx Specialty Pharmacy and RxCrossroads by McKesson Collaborate to Streamline the Channel for Precision Medicine Therapies

PANTHERxยฎ Specialty Pharmacy, The Rare Disease Specialty Pharmacy , and RxCrossroadsย  by McKesson, the leading commercial solutions partner for life sciences companies, announced their...

New Analyses on Mortality from the 18,924-Patient ODYSSEY OUTCOMES Trial

Regeneron Pharmaceuticals, Inc. and Sanofi announced that new analyses on mortality from the 18,924-patient ODYSSEY OUTCOMES trial were presented at the American Heart Association...

AstraZeneca provides update on the Phase III MYSTIC trial of Imfinzi and tremelimumab in Stage IV

AstraZeneca and MedImmune, its global biologics research and development arm, announced final overall survival (OS) results for the Phase III MYSTIC trial. ...

ADC Bio secures additional equity round investment

ADC Biotechnology , announces that it has secured additional funding of ยฃ2.5 million from existing investors and company management. The investment...

Quanticate Sponsors Research into Response Adaptive Trial Design

Quanticate, a data-focused clinical research organisation (CRO), has announced that it is partnering with Lancaster University to sponsor a STOR-i PhD project. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read